Extraction and visualization of potential pharmacophore points using support vector machines: application to ligand-based virtual screening for COX-2 inhibitors.

Article Details

Citation
Copy to clipboard

Franke L, Byvatov E, Werz O, Steinhilber D, Schneider P, Schneider G

Extraction and visualization of potential pharmacophore points using support vector machines: application to ligand-based virtual screening for COX-2 inhibitors.

J Med Chem. 2005 Nov 3;48(22):6997-7004.

PubMed ID
16250658 [ View in PubMed
]
Abstract

Support vector machines (SVM) were trained to predict cyclooxygenase 2 (COX-2) and thrombin inhibitors. The classifiers were obtained using sets of known COX-2 and thrombin inhibitors as "positive examples" and a large collection of screening compounds as "negative examples". Molecules were encoded by topological pharmacophore-point triangles. In retrospective virtual screening, 50-90% of the known active compounds were listed within the first 0.1% of the ranked database. To check the validity of the constructed classifiers, we developed a method for feature extraction and visualization using SVM. As a result, potential pharmacophore points were weighted according to their importance for COX-2 and thrombin inhibition. Known thrombin and COX-2 pharmacophore points were correctly recognized by the machine learning system. In a prospective virtual screening study, several potential COX-2 inhibitors were predicted and tested in a cellular activity assay. A benzimidazole derivative exhibited significant inhibitory activity with an IC(50) of 0.2 microM, which is better than Celecoxib in our assay. It was demonstrated that the SVM machine-learning method can be used in virtual screening and be analyzed in a human-interpretable way that results in a set of rules for designing novel molecules.

DrugBank Data that Cites this Article

Binding Properties
DrugTargetPropertyMeasurementpHTemperature (°C)
CelecoxibProstaglandin G/H synthase 2IC 50 (nM)6N/AN/ADetails
CelecoxibProstaglandin G/H synthase 2IC 50 (nM)6.8N/AN/ADetails
DiclofenacProstaglandin G/H synthase 2IC 50 (nM)5N/AN/ADetails
DiclofenacProstaglandin G/H synthase 2IC 50 (nM)26N/AN/ADetails
RofecoxibProstaglandin G/H synthase 2IC 50 (nM)15N/AN/ADetails
RofecoxibProstaglandin G/H synthase 2IC 50 (nM)25N/AN/ADetails